Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates

Core Viewpoint - Alphatec reported a quarterly loss of $0.28 per share, slightly worse than the Zacks Consensus Estimate of a loss of$ 0.27, but an improvement from a loss of $0.35 per share a year ago [1] - The company posted revenues of$ 150.72 million for the quarter ended September 2024, exceeding the Zacks Consensus Estimate by 2.19% and showing a year-over-year increase from $118.26 million [2] Financial Performance - The quarterly report indicates an earnings surprise of -3.70%, with the company having consistently failed to surpass consensus EPS estimates over the last four quarters [1][2] - Alphatec shares have declined approximately 64.1% year-to-date, contrasting with the S&P 500's gain of 22.3% [3] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at -$ 0.18 for the upcoming quarter and -$1.08 for the current fiscal year [7] - The estimate revisions trend for Alphatec is currently favorable, resulting in a Zacks Rank 2 (Buy), suggesting that the shares are expected to outperform the market in the near future [6] Industry Context - The Medical - Instruments industry, to which Alphatec belongs, is currently ranked in the top 22% of over 250 Zacks industries, indicating a positive outlook for stocks within this sector [8] - The performance of Alphatec's stock may also be influenced by the overall industry outlook and trends in earnings estimate revisions [5][8]